À¯·´ÀÇ ¾Ï À¯ÀüÀÚ ÆÐ³Î ¹× ÇÁ·ÎÆÄÀϸµ ½ÃÀå : ºÐ¼® ¹× ¿¹Ãø(2023-2033³â)
Europe Genomic Cancer Panel and Profiling Market: Analysis and Forecast, 2023-2033
»óǰÄÚµå : 1408631
¸®¼­Ä¡»ç : BIS Research Inc.
¹ßÇàÀÏ : 2024³â 01¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 2,950 £Ü 4,268,000
PDF and Excel (1-3 User License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 3¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,450 £Ü 6,438,000
PDF and Excel (Global License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

2023³â ÇöÀç À¯·´ÀÇ À¯Àüü ¾Ï ÆÐ³Î ¹× ÇÁ·ÎÆÄÀϸµ ½ÃÀå ±Ô¸ð´Â 26¾ï 4,000¸¸ ´Þ·¯À̸ç, 2033³â¿¡´Â 65¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¿¹Ãø ±â°£ÀÎ 2023-2033³â°£ 9.42%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ ¼ºÀåÀÇ ¿øµ¿·ÂÀº À¯Àüü ¿¬±¸ÀÇ ¹ßÀü°ú Á¾¾çÇп¡¼­ Á¤¹ÐÄ¡·á¿¡ ´ëÇÑ Á߿伺ÀÌ ³ô¾ÆÁö°í Àֱ⠶§¹®ÀÔ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
¿¹Ãø ±â°£ 2023³â-2033³â
2023³â Æò°¡ 26¾ï 4,000¸¸ ´Þ·¯
2033³â Àü¸Á 65¾ï ´Þ·¯
CAGR 9.42%

À¯Àüü ¾Ï ÆÐ³Î°ú ÇÁ·ÎÆÄÀϸµÀº Áõ»óÀÌ ³ªÅ¸³ª±â Àü¿¡ ¾Ç¼º Á¾¾çÀÇ À¯ÀüÀû Ư¡À» °Ë»çÇÏ´Â Çö´ëÀû ¾Ï Áø´Ü ¹æ¹ýÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ÆÐ³ÎÀº ±¤¹üÀ§ÇÑ À¯ÀüÇÐÀû ÅëÂû·ÂÀ» Á¦°øÇÔÀ¸·Î½á Á¶±â ¹ß°ßÀ» ¿ëÀÌÇÏ°Ô ÇÏ°í ¸ÂÃãÇü Ä¡·á Àü·« °³¹ßÀ» ¿ëÀÌÇÏ°Ô ÇÑ´Ù´Â Å« ÀÌÁ¡ÀÌ ÀÖ½À´Ï´Ù. ¾Ï À¯ÀüÀÚ ÆÐ³Î ¹× ÇÁ·ÎÆÄÀϸµ ½ÃÀåÀÌ ¼ºÀåÇÏ´Â ÀÌÀ¯´Â ÀÌ·¯ÇÑ ±â¼úÀÌ ¾Ï °ü¸®¸¦ º¯È­½Ãų ¼ö ÀÖ´Â Çõ½ÅÀû ÀáÀç·ÂÀ» °¡Áö°í Àֱ⠶§¹®ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ÆÐ³ÎÀº ÀÇ·á ¼­ºñ½º Á¦°ø¾÷ü°¡ ƯÁ¤ À¯ÀüÀû º¯È­¸¦ ½Äº°ÇÏ°í ±×¿¡ µû¶ó °³ÀÔÀ» ¸ÂÃãÈ­ÇÒ ¼ö ÀÖµµ·Ï ÇÔÀ¸·Î½á ¾Ï À¯ÀüÇп¡ ´ëÇÑ ÀÌÇØ¸¦ Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù.

À¯·´ ½ÃÀå¿¡¼­´Â À¯ÀüÀÚ ¾Ï ÆÐ³Î°ú ÇÁ·ÎÆÄÀϸµÀÌ ¾Ï °ËÁø ¹× °ü¸®¸¦ À§ÇØ Àα⸦ ²ø°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ãֽбâ¼úÀº ¾Ç¼º Á¾¾ç¿¡ ´ëÇÑ »ó¼¼ÇÑ À¯ÀüÀÚ Á¤º¸¸¦ Á¦°øÇÏ¿© Á¶±â ¹ß°ß°ú ¸ÂÃã Ä¡·á ¿ä¹ýÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ÆÐ³ÎÀº ¾Ï °ü¸®¸¦ Çõ½ÅÀûÀ¸·Î º¯È­½Ãų ¼ö Àֱ⠶§¹®¿¡ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. À¯·´ ½ÃÀå È®´ë ¿äÀÎÀ¸·Î´Â ¾×ü »ý°Ë °Ë»çÀÇ º¸±Þ, »ýȰ½À°ü º¯È­·Î ÀÎÇÑ ¾Ï À§Çè Áõ°¡, Á¶±â ¹ß°ßÀÇ Çʿ伺 µîÀÌ ²ÅÈü´Ï´Ù.

ÀÌ º¸°í¼­´Â À¯·´ÀÇ ¾Ï À¯ÀüÀÚ ÆÐ³Î ¹× ÇÁ·ÎÆÄÀϸµ ½ÃÀå¿¡ ´ëÇØ Á¶»çÇßÀ¸¸ç, ½ÃÀå °³¿ä¿Í ÇÔ²² ¿ëµµº°/ÃÖÁ¾ »ç¿ëÀÚº°/±¹°¡º° µ¿Çâ, ½ÃÀå ÁøÃâ±â¾÷ ÇÁ·ÎÆÄÀÏ µîÀÇ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

ÁÖ¿ä ¿ä¾à

Á¦1Àå ½ÃÀå

Á¦2Àå ¾÷°è ºÐ¼®

Á¦3Àå ½ÃÀå ¿ªÇÐ

Á¦4Àå °æÀï ÀλçÀÌÆ®

Á¦5Àå Áö¿ªº°

Á¦6Àå ±â¾÷ °³¿ä

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

“The Europe Genomic Cancer Panel and Profiling Market Expected to Reach $6.50 Billion by 2033.”

Introduction to Europe Genomic Cancer Panel and Profiling Market

As of 2023, the Europe genomic cancer panel and profiling market was valued at $2.64 billion and is expected to attain a value of $6.50 billion in 2033. The market is anticipated to grow at a CAGR of 9.42% during the forecast period 2023-2033. This growth is being driven by advances in genomic research and an increasing emphasis on precision therapy in oncology.

KEY MARKET STATISTICS
Forecast Period2023 - 2033
2023 Evaluation$2.64 Billion
2033 Forecast$6.50 Billion
CAGR9.42%

Market Introduction

Genomic cancer panels and profiling are a contemporary technique to cancer detection that examines the genetic characteristics of malignancies before symptoms occur. The capacity of these panels to provide extensive genetic insights facilitates early detection and the development of tailored treatment strategies, which is a considerable advantage. The genomic cancer panel and profiling market is expanding because to the transformational potential these technologies have for changing cancer management. These panels improve our understanding of cancer genetics by allowing healthcare providers to identify particular genetic changes and customize interventions accordingly.

In the European market, genetic cancer panels and profiling are gaining popularity for cancer screening and management. These modern technologies provide detailed genetic information about malignancies, allowing for early detection and individualized treatment regimens. The demand for these panels is increasing as a result of their transformational potential in changing cancer management. Factors driving market expansion in Europe include the growing popularity of liquid biopsy testing, increased cancer risk due to lifestyle changes, and the need for early detection.

Market Segmentation

Segmentation 1: by Application

Segmentation 2: by End User

Segmentation 3: by Country

How can this report add value to an organization?

Product/Innovation Strategy: The Europe genomic cancer panel and profiling market has been extensively segmented based on various categories, such as application, end user, and country. This can help readers get a clear overview of the segments accounting for the largest share and the ones that are well-positioned to grow in the coming years.

Table of Contents

Executive Summary

1. Markets

2. Industry Analysis

3. Market Dynamics

4. Competitive Insights

5. By Region

6. Company Profiles

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â